{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T05:44:41Z","timestamp":1791783881772,"version":"4.3.4"},"reference-count":144,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004595","name":"Science University of Malaysia","doi-asserted-by":"publisher","award":["R502-KR-ARU001-0000002314-K134"],"award-info":[{"award-number":["R502-KR-ARU001-0000002314-K134"]}],"id":[{"id":"10.13039\/501100004595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.bbamcr.2026.120235","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:32:44Z","timestamp":1791318764000},"page":"120235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phytochemical\u2013drug combinations in osteosarcoma: Mechanistic vulnerabilities, evidence quality and translational challenges"],"prefix":"10.1016","volume":"1874","author":[{"given":"Nor Munira","family":"Hashim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermizi","family":"Hapidin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbamcr.2026.120235_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2025.102952","article-title":"Synergistic composite engineering: bridging immunomodulaftion, bone regeneration and precision therapy in osteosarcoma management","volume":"67","author":"You","year":"2026","journal-title":"Nano Today"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115953","article-title":"Modern trends of using innovative nanoparticle approaches for immune-based osteosarcoma therapy","volume":"168","author":"Kausar","year":"2026","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120235_bb0015","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s12672-025-02208-9","article-title":"Systemic strategies for osteosarcoma: advances and future directions","volume":"16","author":"Morya","year":"2025","journal-title":"Discov. Oncol."},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120235_bb0020","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41416-024-02868-4","article-title":"UK guidelines for the management of bone sarcomas","volume":"132","author":"Gerrand","year":"2025","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120235_bb0025","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-026-15802-z","article-title":"Risk factors for pulmonary metastases in osteosarcoma: a systematic review and meta-analysis","volume":"26","author":"Dai","year":"2026","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0030","article-title":"Prognostic nomogram for overall survival in pediatric osteosarcoma with pulmonary metastases: a SEER database analysis","volume":"13\u20132025","author":"Tang","year":"2025","journal-title":"Front. Pediatr."},{"issue":"2","key":"10.1016\/j.bbamcr.2026.120235_bb0035","article-title":"From bone homeostasis to skeletal metastasis and osteosarcoma: insights into osteoclast and osteoblast roles in bone remodelling and cancer","volume":"1881","author":"Kottmann","year":"2026","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.780264","article-title":"Osteosarcoma and metastasis","volume":"11","author":"Sheng","year":"2021","journal-title":"Front. Oncol."},{"issue":"04","key":"10.1016\/j.bbamcr.2026.120235_bb0045","doi-asserted-by":"crossref","first-page":"530","DOI":"10.4103\/ijmpo.ijmpo_83_17","article-title":"Recurrent metastatic high-grade osteosarcoma: disease stabilization and successful pregnancy outcome following aggressive multimodality treatment","volume":"39","author":"Khurana","year":"2018","journal-title":"Indian J Med Paediatr Oncol"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2026.105252","article-title":"Advances in osteosarcoma research: pathogenesis and emerging therapeutic strategies","volume":"222","author":"Yan","year":"2026","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12082785","article-title":"Osteosarcoma: current concepts and evolutions in management principles","volume":"12","author":"Pilavaki","year":"2023","journal-title":"J. Clin. Med."},{"issue":"19","key":"10.1016\/j.bbamcr.2026.120235_bb0060","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000015582","article-title":"Methotrexate, doxorubicin, and cisplatinum regimen is still the preferred option for osteosarcoma chemotherapy: a meta-analysis and clinical observation","volume":"98","author":"Yu","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1016\/j.bbamcr.2026.120235_bb0065","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S1470-2045(16)30214-5","article-title":"Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial","volume":"17","author":"Marina","year":"2016","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120235_bb0070","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12957-026-04364-w","article-title":"Completion of perioperative chemotherapy and tumor regression grade as independent predictors of one-year survival after total gastrectomy for gastric cancer: a retrospective cohort study","volume":"24","author":"Aldarwish","year":"2026","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0075","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.3390\/cancers18111718","article-title":"Pathological complete response after neoadjuvant chemotherapy in breast cancer: a literature overview","volume":"18","author":"Gorzelak-Magiera","year":"2026","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120235_bb0080","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00432-025-06410-8","article-title":"Long-term benefit from high-dose ifosfamide in sarcoma depends on sustained prior control and timely intervention: a machine learning analysis","volume":"152","author":"Hoberger","year":"2026","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0085","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.3390\/cells9112389","article-title":"High dose ifosfamide in relapsed and unresectable high-grade osteosarcoma patients: a retrospective series","author":"Palmerini","year":"2020","journal-title":"Cells"},{"issue":"17","key":"10.1016\/j.bbamcr.2026.120235_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179451","article-title":"Battling Chemoresistance in cancer: root causes and strategies to uproot them","volume":"22","author":"Ramos","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2026.102886","article-title":"Mechanisms and advances of drug resistance in colorectal cancer: a systematic overview of multi-layered regulatory networks","volume":"71","author":"Qiu","year":"2026","journal-title":"Transl. Oncol."},{"issue":"4","key":"10.1016\/j.bbamcr.2026.120235_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/ph18040520","article-title":"Advancements in osteosarcoma therapy: overcoming chemotherapy resistance and exploring novel pharmacological strategies","volume":"18","author":"Zhra","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120235_bb0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.gendis.2022.11.025","article-title":"Cancer cell cycle heterogeneity as a critical determinant of therapeutic resistance","volume":"11","author":"Maleki","year":"2024","journal-title":"Genes & Diseases"},{"issue":"4","key":"10.1016\/j.bbamcr.2026.120235_bb0110","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","article-title":"Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics","volume":"10","author":"Anand","year":"2023","journal-title":"Genes & Diseases"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0115","doi-asserted-by":"crossref","DOI":"10.1039\/D6DT01362G","article-title":"Emerging therapeutic strategies for triple-negative breast cancer using ruthenium, iridium, and rhenium complexes","author":"Das","year":"2026","journal-title":"Dalton Trans."},{"issue":"9","key":"10.1016\/j.bbamcr.2026.120235_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e10608","article-title":"Cisplatin for cancer therapy and overcoming chemoresistance","volume":"8","author":"Ranasinghe","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106939","article-title":"Advances in understanding cisplatin-induced toxicity: molecular mechanisms and protective strategies","volume":"203","author":"Elmorsy","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0130","article-title":"Cisplatin resistance in oral squamous cell carcinoma: mechanisms, reversal strategies, and emerging technologies","volume":"17\u20132026","author":"Shi","year":"2026","journal-title":"Front. Physiol."},{"issue":"21","key":"10.1016\/j.bbamcr.2026.120235_bb0135","doi-asserted-by":"crossref","first-page":"10248","DOI":"10.1021\/acs.chemrev.5c00041","article-title":"Colorectal cancer at the crossroads: the good, the bad, and the future of platinum-based drugs","volume":"125","author":"Kee","year":"2025","journal-title":"Chem. Rev."},{"issue":"4","key":"10.1016\/j.bbamcr.2026.120235_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/cells12040659","article-title":"Doxorubicin-an agent with multiple mechanisms of anticancer activity","volume":"12","author":"Kciuk","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0145","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/hearts5010005","article-title":"Different mechanisms in doxorubicin-induced cardiomyopathy: impact of BRCA1 and BRCA2 mutations","author":"Nguyen","year":"2024","journal-title":"Hearts"},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120235_bb0150","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12906-026-05397-0","article-title":"Resistance to doxorubicin therapy in breast cancer cells could be attenuated by ligustilide: impact on autophagy and LncRNA H19","volume":"26","author":"Amr","year":"2026","journal-title":"BMC Complementary Med. Ther."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0155","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.3390\/ijms27062792","article-title":"Targeting activated pathways in doxorubicin-resistant TNBC alters signaling, survival and EMT: a double-edged sword","volume":"27","author":"Dogan Turacli","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20205023","article-title":"Methotrexate an old drug with new tricks","volume":"20","author":"Bedoui","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0165","article-title":"A narrative review on diagnosis and treatment of ifosfamide-induced encephalopathy, the perspective of a EURACAN reference center for sarcomas","volume":"16\u20132025","author":"Torchia","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbamcr.2026.120235_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/ctd2.202","article-title":"The heterogeneity and drug resistance of malignant cells and intercellular communication of microenvironment in osteosarcoma: based on single-cell analysis","volume":"3","author":"Ma","year":"2023","journal-title":"Clinical and Translational Discovery"},{"issue":"5","key":"10.1016\/j.bbamcr.2026.120235_bb0175","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.3892\/ol.2014.1935","article-title":"Molecular mechanisms of chemoresistance in osteosarcoma (review)","volume":"7","author":"He","year":"2014","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120235_bb0180","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-\u03baB in biology and targeted therapy: new insights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101510","article-title":"Key signal transduction pathways and crosstalk in cancer: biological and therapeutic opportunities","volume":"26","author":"Fu","year":"2022","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0190","article-title":"Metabolic\u2013immune crosstalk in osteosarcoma: mechanisms and therapeutic opportunities","volume":"17\u20132026","author":"Wan","year":"2026","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bbamcr.2026.120235_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.gendis.2025.101569","article-title":"Tumor microenvironment in osteosarcoma: from cellular mechanism to clinical therapy","volume":"12","author":"Yu","year":"2025","journal-title":"Genes & Diseases"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2026.105204","article-title":"Targeting redox homeostasis in cancer: inhibitors of reactive oxygen species regulating cellular signalling pathways and their therapeutic implications","volume":"221","author":"Sahu","year":"2026","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102754","article-title":"Drug-induced oxidative stress in cancer treatments: angel or devil?","volume":"63","author":"Jiang","year":"2023","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120235_bb0210","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41392-026-02583-x","article-title":"Reactive oxygen species (ROS) in cancer: from mechanism to therapeutic implications","volume":"11","author":"Akter","year":"2026","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.nexres.2026.101908","article-title":"The significance of antioxidants and their cellular mechanisms that defend against oxidative stress: a review","volume":"10","author":"Dilshad","year":"2026","journal-title":"Next Research"},{"issue":"11","key":"10.1016\/j.bbamcr.2026.120235_bb0220","article-title":"Nonapoptotic cell death pathways","volume":"14","author":"Green","year":"2022","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"9","key":"10.1016\/j.bbamcr.2026.120235_bb0225","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41573-023-00749-8","article-title":"The therapeutic potential of targeting regulated non-apoptotic cell death","volume":"22","author":"Hadian","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120235_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.lddd.2026.100363","article-title":"Phytochemicals as promising lead compounds for drug discovery: a comprehensive review of mechanisms and pharmacological potentials","volume":"23","author":"Idakwoji","year":"2026","journal-title":"Lett. Drug Des. Discovery"},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120235_bb0235","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s44371-026-00781-8","article-title":"Phytochemicals from natural sources classification physiological roles and health benefits","volume":"3","author":"Kafi","year":"2026","journal-title":"Discover Chemistry"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.crphar.2023.100167","article-title":"Flavonoids as promising molecules in the cancer therapy: an insight","volume":"6","author":"Mir","year":"2024","journal-title":"Current Research in Pharmacology and Drug Discovery"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.fbio.2024.105741","article-title":"Anticancer properties of phenolic acids and cell death signaling pathways: a 20-year bibliometric analysis (2003\u22122023)","volume":"63","author":"Silva","year":"2025","journal-title":"Food Bioscience"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0250","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.3390\/molecules28145578","article-title":"Therapeutic role of alkaloids and alkaloid derivatives in Cancer management","author":"Olofinsan","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0255","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.3390\/cancers14051100","article-title":"Therapeutic potential of certain Terpenoids as anticancer agents: a scoping review","author":"Kamran","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2025.169109","article-title":"Multi-target saponins in cancer therapy: direct binding mechanisms and lipid-based nanoparticles as a synergistic solution","volume":"524","author":"Kim","year":"2025","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2024.101432","article-title":"Quinone scaffolds as potential therapeutic anticancer agents: chemistry, mechanism of actions, structure-activity relationships and future perspectives","volume":"7","author":"Faizan","year":"2024","journal-title":"Results in Chemistry"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0270","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jot.2021.12.001","article-title":"Baicalein mediates the anti-tumor activity in osteosarcoma through lncRNA-NEF driven Wnt\/beta-catenin signaling regulatory axis","volume":"33","author":"Zhang","year":"2022","journal-title":"J Orthop Translat"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2022.100415","article-title":"Baicalin induces apoptosis and autophagy in human osteosarcoma cells by increasing ROS to inhibit PI3K\/Akt\/mTOR, ERK1\/2 and beta-catenin signaling pathways","volume":"33","author":"Pang","year":"2022","journal-title":"J Bone Oncol"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111420","article-title":"Pulsatilla saponin D inhibited the growth of osteosarcoma by regulating the JNK\/ATF3 signaling pathway","volume":"410","author":"Jin","year":"2025","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.178432","article-title":"Robinetin inhibits osteosarcoma proliferation and migration, acting via the slug\/twist signaling axis","volume":"1011","author":"Santos","year":"2026","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117967","article-title":"Magnoflorine inhibits the malignant phenotypes and increases cisplatin sensitivity of osteosarcoma cells via regulating miR-410-3p\/HMGB1\/NF-kappaB pathway","volume":"256","author":"Wang","year":"2020","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120235_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s44178-025-00217-w","article-title":"Recent advances and future perspectives in multidisciplinary research on osteosarcoma","volume":"5","author":"Bao","year":"2026","journal-title":"Holist. Integr. Oncol."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0300","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3390\/antiox15020272","article-title":"Phytochemicals and REDOX modulation: molecular mechanisms, clinical relevance, and therapeutic perspectives","author":"Singh","year":"2026","journal-title":"Antioxidants"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0305","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.3390\/ijms25063264","article-title":"Oxidative stress: the role of antioxidant phytochemicals in the prevention and treatment of diseases","author":"Muscolo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103686","article-title":"Targeting oxidative stress-mediated regulated cell death as a vulnerability in cancer","volume":"84","author":"Chen","year":"2025","journal-title":"Redox Biol."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0315","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.actbio.2025.07.067","article-title":"The role of redox homeostasis in tumor progression: implications for cancer therapy","volume":"204","author":"Liu","year":"2025","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.chphi.2026.101054","article-title":"Precision redox oncology: exploiting antioxidant dependencies and oxidative vulnerabilities in cancer","volume":"12","author":"Sulaiman","year":"2026","journal-title":"Chemical Physics Impact"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2026.177700","article-title":"Targeting metabolic redox vulnerabilities via a multi-modal MOF nanoplatform for synergistic ROS-mediated cancer therapy","volume":"541","author":"Wu","year":"2026","journal-title":"Chem. Eng. J."},{"issue":"6","key":"10.1016\/j.bbamcr.2026.120235_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09519","article-title":"Synergistic effects of natural compounds and conventional chemotherapeutic agents: recent insights for the development of cancer treatment strategies","volume":"8","author":"Casta\u00f1eda","year":"2022","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120235_bb0335","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12986-026-01094-4","article-title":"Natural bioactive molecules and chemotherapeutics synergism for enhanced cancer therapy","volume":"23","author":"Hashemi","year":"2026","journal-title":"Nutr. Metab."},{"issue":"2","key":"10.1016\/j.bbamcr.2026.120235_bb0340","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.tjnut.2024.11.015","article-title":"Understanding the anticancer effects of phytochemicals: from molecular docking to Anticarcinogenic signaling","volume":"155","author":"Tian","year":"2025","journal-title":"J. Nutr."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0345","article-title":"Phytochemicals as a complement to Cancer chemotherapy: pharmacological modulation of the autophagy-apoptosis pathway","volume":"12\u20132021","author":"Rahman","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120235_bb0350","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12935-025-04109-x","article-title":"Deciphering the cancer chemopreventive potential of phytochemicals: an integrative perspective on molecular targets and signaling networks","volume":"26","author":"Kaur","year":"2026","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156960","article-title":"Formononetin enhances cisplatin chemotherapy sensitivity in osteosarcoma by inducing ferroptosis and reconstructing the immune microenvironment","volume":"145","author":"Liu","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2022.105118","article-title":"EGCG regulated osteolytic microenvironment to enhance the antitumor effect of DOX on orthotopic osteosarcoma","volume":"94","author":"Hu","year":"2022","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2024.106339","article-title":"Lycorine combined with cisplatin synergistically inhibited osteosarcoma cells growth and metastasis by suppressing Wnt\/\u03b2-catenin and STAT3 signaling pathways","volume":"119","author":"Liu","year":"2024","journal-title":"J. Funct. Foods"},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120235_bb0370","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s43440-021-00330-3","article-title":"Tannic acid enhances cisplatin effect on cell proliferation and apoptosis of human osteosarcoma cell line (U2OS)","volume":"74","author":"Kasiram","year":"2022","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113323","article-title":"Pectolinarigenin acts as a potential anti-osteosarcoma agent via mediating SHP-1\/JAK2\/STAT3 signaling","volume":"153","author":"Zhang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117284","article-title":"Chalcones induce apoptosis, autophagy and reduce spreading in osteosarcoma 3D models","volume":"179","author":"Rossi","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120235_bb0385","article-title":"Veratramine influences the proliferation of human osteosarcoma cells through modulating the PI3K\/AKT signaling cascade","volume":"13","author":"Xie","year":"2026","journal-title":"Genes Dis"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114126","article-title":"Anti-osteosarcoma activity of Corynoline via Src\/JNK signaling-mediated cell cycle arrest and mitochondrial apoptosis","volume":"148","author":"Li","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155430","article-title":"9-O-monoethyl succinate berberine effectively blocks the PI3K\/AKT signaling pathway by targeting Wnt5a protein in inhibiting osteosarcoma growth","volume":"132","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108557","article-title":"Harmine exerts anticancer effects through the ROS\/p38 axis to induce autophagy and apoptosis in osteosarcoma","volume":"161","author":"Yu","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153186","article-title":"Rosmarinic acid exerts an anticancer effect on osteosarcoma cells by inhibiting DJ-1 via regulation of the PTEN-PI3K-Akt signaling pathway","volume":"68","author":"Ma","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2022.105521","article-title":"Acetylshikonin induces apoptosis of human osteosarcoma U2OS cells by triggering ROS-dependent multiple signal pathways","volume":"86","author":"Cha","year":"2023","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2022.105103","article-title":"Acacetin inhibits the tumor growth of human osteosarcoma cells through regulating Wnt\/\u03b2-catenin and JNK signaling pathways","volume":"93","author":"Wei","year":"2022","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2020.104775","article-title":"Piperlongumine induces apoptosis and G(2)\/M phase arrest in human osteosarcoma cells by regulating ROS\/PI3K\/Akt pathway","volume":"65","author":"Zhou","year":"2020","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156464","article-title":"Brusatol inhibits malignant phenotypes and lipid metabolism of osteosarcoma cells by regulating PI3K\/AKT and MAPK pathways","volume":"139","author":"Yuan","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156949","article-title":"Guggulsterone suppresses osteosarcoma progression by inhibiting glycolysis through MAPK signaling pathway","volume":"144","author":"Wang","year":"2025","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120235_bb0435","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.intimp.2014.11.012","article-title":"Piperine inhibits proliferation of human osteosarcoma cells via G2\/M phase arrest and metastasis by suppressing MMP-2\/\u22129 expression","volume":"24","author":"Zhang","year":"2015","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.bbamcr.2026.120235_bb0440","first-page":"354","article-title":"Ziyuglycoside II suppressed the progression of osteosarcoma by coordinating estrogen-related receptor gamma and p53 signaling pathway","volume":"23","author":"Du","year":"2025","journal-title":"Chin. J. Nat. Med."},{"issue":"3","key":"10.1016\/j.bbamcr.2026.120235_bb0445","article-title":"Reactive oxygen species signaling and oxidative stress: transcriptional regulation and evolution","volume":"13","author":"Hong","year":"2024","journal-title":"Antioxidants (Basel)"},{"issue":"18","key":"10.1016\/j.bbamcr.2026.120235_bb0450","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1016\/j.molcel.2021.08.018","article-title":"Redox metabolism: ROS as specific molecular regulators of cell signaling and function","volume":"81","author":"Lennicke","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156912","article-title":"Brusatol induced ferroptosis in osteosarcoma cells by modulating the Keap1\/Nrf2\/SLC7A11 signaling pathway","volume":"144","author":"Zhang","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0460","article-title":"Licochalcone B targets neural cell adhesion molecule 1 to inhibit osteosarcoma progression and ferroptosis resistance via extracellular signal-regulated kinase 5 and nuclear factor kappa B pathways","volume":"150","author":"Wang","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119501","article-title":"Piperlongumine inhibits the progression of osteosarcoma by downregulating the SOCS3\/JAK2\/STAT3 pathway via miR-30d-5p","volume":"277","author":"Hu","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2021.101705","article-title":"Anti-tumour potential and selectivity of caffeic acid phenethyl ester in osteosarcoma cells","volume":"74","author":"Pagnan","year":"2022","journal-title":"Tissue Cell"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153642","article-title":"Dihydromyricetin suppresses cell metastasis in human osteosarcoma through SP-1- and NF-kappaB-modulated urokinase plasminogen activator inhibition","volume":"90","author":"Chou","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155716","article-title":"Ziyuglycoside II, a triterpene glycoside compound in Sanguisorbae officinalis l. extract, suppresses metastasis in osteosarcoma via CBX4-mediated Wnt\/beta-catenin signal pathway","volume":"132","author":"Deng","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157066","article-title":"Antitumor effects of cannabidiol (CBD) on osteosarcoma by targeting TNF-alpha\/NF-kappaB\/CCL5 signaling axis","volume":"145","author":"Yang","year":"2025","journal-title":"Phytomedicine"},{"issue":"3","key":"10.1016\/j.bbamcr.2026.120235_bb0490","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jphs.2022.08.005","article-title":"Rhizoma Paridis saponins suppresses vasculogenic mimicry formation and metastasis in osteosarcoma through regulating miR-520d-3p\/MIG-7 axis","volume":"150","author":"Yao","year":"2022","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2024.106210","article-title":"Cyclovirobuxine D inhibits the growth of osteosarcoma cells through the induction of autophagy flux arrest by promoting lysosomal acidification","volume":"116","author":"Liang","year":"2024","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2024.100657","article-title":"Naringenin induces ferroptosis in osteosarcoma cells through the STAT3-MGST2 signaling pathway","volume":"50","author":"Li","year":"2025","journal-title":"J Bone Oncol"},{"issue":"2","key":"10.1016\/j.bbamcr.2026.120235_bb0505","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14020360","article-title":"Metastatic progression of osteosarcomas: a review of current knowledge of environmental versus oncogenic drivers","volume":"14","author":"Odri","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0510","article-title":"Mechanisms of angiogenesis in tumour","volume":"14","author":"Zhang","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117585","article-title":"Physiological and tumor-associated angiogenesis: key factors and therapy targeting VEGF\/VEGFR pathway","volume":"180","author":"Lorenc","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120235_bb0520","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13046-024-02949-5","article-title":"Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery","volume":"43","author":"Hu","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.bbamcr.2026.120235_bb0525","article-title":"STAT3 axis in cancer and cancer stem cells: from oncogenesis to targeted therapies, Biochimica et Biophysica Acta (BBA) - reviews on","volume":"1880","author":"Godugu","year":"2025","journal-title":"Cancer"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2025.102745","article-title":"Curculigoside exhibits multiple therapeutic ef fi cacy to induce apoptosis and ferroptosis in osteosarcoma via modulation of ROS and tumor microenvironment","volume":"93","author":"Ma","year":"2025","journal-title":"Tissue Cell"},{"issue":"12","key":"10.1016\/j.bbamcr.2026.120235_bb0535","doi-asserted-by":"crossref","DOI":"10.3390\/ph18121785","article-title":"Ferroptosis, a distinct form of cell death, and research progress on its modulators","volume":"18","author":"Chen","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120235_bb0540","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41420-024-01825-7","article-title":"Ferroptosis: emerging mechanisms, biological function, and therapeutic potential in cancer and inflammation","volume":"10","author":"Jin","year":"2024","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.bbamcr.2026.120235_bb0545","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120235_bb0550","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41420-021-00579-w","article-title":"Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases","volume":"7","author":"Yu","year":"2021","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.bbamcr.2026.120235_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.mocell.2025.100276","article-title":"Brief guide to detecting ferroptosis","volume":"48","author":"Thi Nghiem","year":"2025","journal-title":"Mol. Cells"},{"issue":"6","key":"10.1016\/j.bbamcr.2026.120235_bb0560","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","article-title":"The cell biology of ferroptosis","volume":"25","author":"Dixon","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.bbamcr.2026.120235_bb0565","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.4251\/wjgo.v15.i7.1135","article-title":"Interaction mechanisms between autophagy and ferroptosis: potential role in colorectal cancer","volume":"15","author":"Zeng","year":"2023","journal-title":"World J. Gastrointest. Oncol."},{"issue":"5","key":"10.1016\/j.bbamcr.2026.120235_bb0570","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"R. Skouta, Eleina M. Zaitsev, Caroline E. Gleason, Darpan N. Patel, Andras J. Bauer, Alexandra M. Cantley, Wan S. Yang, B. Morrison, Brent R. Stockwell, Ferroptosis: An Iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2024.106488","article-title":"A natural protopanaxatriol from Panax notoginseng enhances osteosarcoma sensitivity to ferroptosis via ASCL4 upregulation","volume":"122","author":"Chen","year":"2024","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2021.103105","article-title":"DNA damage response and repair in osteosarcoma: defects, regulation and therapeutic implications","volume":"102","author":"Sadoughi","year":"2021","journal-title":"DNA Repair"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.crphar.2022.100110","article-title":"Evaluation of synergism in drug combinations and reference models for future orientations in oncology","volume":"3","author":"Duarte","year":"2022","journal-title":"Current Research in Pharmacology and Drug Discovery"},{"issue":"12","key":"10.1016\/j.bbamcr.2026.120235_bb0590","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1016\/j.drudis.2019.09.002","article-title":"Applying synergy metrics to combination screening data: agreements, disagreements and pitfalls","volume":"24","author":"Vlot","year":"2019","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.bbamcr.2026.120235_bb0595","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.gpb.2022.01.004","article-title":"SynergyFinder plus: toward better interpretation and annotation of drug combination screening datasets","volume":"20","author":"Zheng","year":"2022","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodhyd.2022.108165","article-title":"Bioaccessibility and bioavailability of phytochemicals: influencing factors, improvements, and evaluations","volume":"135","author":"Hu","year":"2023","journal-title":"Food Hydrocoll."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157090","article-title":"Exploring the therapeutic potential of phytochemicals: challenges and strategies for clinical translation","volume":"145","author":"Kim","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2022.134351","article-title":"Far from being a simple question: the complexity between in vitro and in vivo responses from nutrients and bioactive compounds with antioxidant potential","volume":"402","author":"Mota","year":"2023","journal-title":"Food Chem."},{"issue":"5","key":"10.1016\/j.bbamcr.2026.120235_bb0615","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s12094-023-03352-w","article-title":"Selection of clinically relevant drug concentrations for in vitro studies of candidates drugs for cancer repurposing: a proposal","volume":"26","author":"Robles-Ba\u00f1uelos","year":"2024","journal-title":"Clin. Transl. Oncol."},{"issue":"12","key":"10.1016\/j.bbamcr.2026.120235_bb0620","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1177\/09622802231212274","article-title":"Estimating drug concentration\u2013response relationships by applying causal inference methods for continuous point exposures and time-to-event outcomes","volume":"32","author":"Yiu","year":"2023","journal-title":"Stat. Methods Med. Res."},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120235_bb0625","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jhip.2026.02.009","article-title":"Exploring synergistic effects of bioactive compounds and pharmaceuticals in therapeutic applications","volume":"7","author":"Akinwumi","year":"2026","journal-title":"Journal of Holistic Integrative Pharmacy"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0630","series-title":"Herb-Drug Combinations: A New Complementary Therapeutic Strategy","first-page":"27","article-title":"Pharmacokinetic interactions in synergistic herb-drug combinations","author":"Hemaiswarya","year":"2022"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.prerep.2025.100067","article-title":"Curcumin as a modulator of drug metabolism and gene expression: implications for pharmacogenomics","volume":"4","author":"Dimeji","year":"2025","journal-title":"Pharmacological Research - Reports"},{"issue":"3","key":"10.1016\/j.bbamcr.2026.120235_bb0640","doi-asserted-by":"crossref","DOI":"10.1177\/15593258221120485","article-title":"Phytochemicals that interfere with drug metabolism and transport, modifying plasma concentration in humans and animals","volume":"20","author":"G\u00f3mez-Gardu\u00f1o","year":"2022","journal-title":"Dose-Response"},{"issue":"8","key":"10.1016\/j.bbamcr.2026.120235_bb0645","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202402479","article-title":"Phytochemicals in Cancer therapy: a structured review of mechanisms, challenges, and Progress in personalized treatment","volume":"22","author":"Aljabali","year":"2025","journal-title":"Chem. Biodivers."},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120235_bb0650","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-12725-w","article-title":"Therapeutic resistance and combination therapy for cancer: recent developments and future directions","volume":"15","author":"Damodaran","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0655","series-title":"Drug Delivery to Tumors: Recent Strategies and Techniques","first-page":"89","article-title":"Combined therapy in Cancer treatment","author":"Ma","year":"2025"},{"issue":"10","key":"10.1016\/j.bbamcr.2026.120235_bb0660","doi-asserted-by":"crossref","first-page":"11149","DOI":"10.1002\/cam4.5698","article-title":"Role of tumor microenvironment in cancer progression and therapeutic strategy","volume":"12","author":"Wang","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0665","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.3390\/curroncol31060241","article-title":"Evaluation of tumor control and Normal tissue complication probabilities in patients receiving comprehensive nodal irradiation for left-sided breast Cancer","author":"Flores-Balc\u00e1zar","year":"2024","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.prenap.2026.100532","article-title":"Nanotechnology-enabled delivery systems to improve the bioavailability and efficacy of polyphenolic compounds","volume":"10","author":"Saran","year":"2026","journal-title":"Pharmacological Research - Natural Products"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0675","article-title":"Liposomes: recent progress on nanoparticles production and their usage in medicine, biomaterials","volume":"180","author":"Peru\u0161","year":"2026","journal-title":"Advances"},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120235_bb0680","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s43246-024-00612-2","article-title":"Recent advances in drug delivery systems for osteosarcoma therapy and bone regeneration","volume":"5","author":"Kortam","year":"2024","journal-title":"Commun. Mater."},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120235_bb0685","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12951-023-01826-1","article-title":"Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics","volume":"21","author":"Shi","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.prerep.2026.100075","article-title":"Nanocarrier-assisted phytochemical drug delivery in cancer therapy: a bibliometric analysis and integrative review of challenges, innovations, and translational potential","volume":"5","author":"Amonkar","year":"2026","journal-title":"Pharmacological Research - Reports"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.plana.2025.100161","article-title":"Nanomaterials for delivery of medicinal plant extracts and phytochemicals: potential applications and future perspectives","volume":"12","author":"Ghosh","year":"2025","journal-title":"Plant Nano Biology"},{"issue":"5","key":"10.1016\/j.bbamcr.2026.120235_bb0700","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1111\/cts.13066","article-title":"3D cell culture models: drug pharmacokinetics, safety assessment, and regulatory consideration","volume":"14","author":"Wang","year":"2021","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.bbamcr.2026.120235_bb0705","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.782766","article-title":"Advancements in 3D cell culture Systems for Personalizing Anti-Cancer Therapies","volume":"11","author":"Law","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120235_bb0710","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s43556-025-00261-y","article-title":"Cancer metastasis: molecular mechanisms and therapeutic interventions","volume":"6","author":"Dai","year":"2025","journal-title":"Mol Biomed"},{"key":"10.1016\/j.bbamcr.2026.120235_bb0715","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jare.2024.10.026","article-title":"Multiple roles of p53 in cancer development: regulation of tumor microenvironment, m6A modification and diverse cell death mechanisms","volume":"75","author":"Wang","year":"2025","journal-title":"J. Adv. Res."},{"issue":"1","key":"10.1016\/j.bbamcr.2026.120235_bb0720","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41392-024-01885-2","article-title":"Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives","volume":"9","author":"Shi","year":"2024","journal-title":"Signal Transduct. Target. Ther."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488926001345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488926001345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T04:45:45Z","timestamp":1791780345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167488926001345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":144,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2027,1]]}},"alternative-id":["S0167488926001345"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamcr.2026.120235","relation":{},"ISSN":["0167-4889"],"issn-type":[{"value":"0167-4889","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phytochemical\u2013drug combinations in osteosarcoma: Mechanistic vulnerabilities, evidence quality and translational challenges","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamcr.2026.120235","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120235"}}